Open AccessPhase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors
Author(s) -
Mercedes Porosnicu,
AnneMarie Quinson,
Kate Crossley,
Stephan Luecke,
Ulrich M. Lauer
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0439
Subject(s) - oncolytic virus , vesicular stomatitis virus , immune system , medicine , immunotherapy , immune checkpoint , virotherapy , virology , cancer , immunology , virus , lymphocytic choriomeningitis , cancer research , cd8
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom